A newly synthesized platinum-based compound (PBC-II) increases chemosensitivity of HeLa ovarian cancer cells via inhibition of autophagy

Alotaibi, 2016, Radiosensitization by PARP inhibition in DNA repair proficient and deficient tumor cells: proliferative recovery in senescent cells, Radiat. Res., 10.1667/RR14202.1 Alotaibi, 2018, Characterization of apoptosis in a breast cancer cell line after IL-10 silencing, Asian Pacific J. Cancer Prev. Bao, 2014, Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma, Int. J. Clin. Exp. Pathol. Beral, 2008, Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls, Lancet Biggers, 2013, Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14, Cancer Chemother. Pharmacol., 10.1007/s00280-012-2024-6 Cheng, 2002, Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: Possible involvement of the phosphoinositide-3 kinase/Akt pathway, Drug Resist. Updat., 10.1016/S1368-7646(02)00003-1 Correa, 2014, Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability, Carcinogenesis, 10.1093/carcin/bgu049 Corti, 2019, Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives, Cancer Treat. Rev., 10.1016/j.ctrv.2018.11.001 Damia, 2019, Platinum resistance in ovarian cancer: Role of DNA repair, Cancers (Basel), 10.3390/cancers11010119 Di, 2009, Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin, Biochem. Pharmacol., 10.1016/j.bcp.2008.12.016 Fang, 2017, Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells, Acta Pharmacol. Sin., 10.1038/aps.2017.25 Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int. J. Cancer, 10.1002/ijc.25516 François, 1976, Study of the lysosomes by vital stains in normal keratocytes and in keratocytes from macular dystrophy of the cornea, Invest. Ophthalmol. Galluzzi, 2017, Molecular definitions of autophagy and related processes, EMBO J., 10.15252/embj.201796697 Gewirtz, 2014, The four faces of autophagy: Implications for cancer therapy, Cancer Res., 10.1158/0008-5472.CAN-13-2966 Goehe, 2012, The autophagy-senescence connection in chemotherapy: Must tumor cells (self) eat before they sleep?, J. Pharmacol. Exp. Ther., 10.1124/jpet.112.197590 He, 2015, Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy, Autophagy., 10.1080/15548627.2015.1009781 Houédé, 2015, Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: Its potential use in the treatment of bladder cancers, Pharmacol. Ther., 10.1016/j.pharmthera.2014.06.004 Huang, 2011, Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome, Genes Chromosom. Cancer, 10.1002/gcc.20883 Iyer, 2012, Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease, Crit. Rev. Immunol., 10.1615/CritRevImmunol.v32.i1.30 Lee, 2015, Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions, Respir. Res., 10.1186/s12931-015-0285-4 Lee, 2005, Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line, Gynecol. Oncol., 10.1016/j.ygyno.2004.11.051 Liang, 2016, Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy, Biomed. Pharmacother., 10.1016/j.biopha.2016.04.054 Liu, 2016, Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells, Cancer Lett., 10.1016/j.canlet.2016.09.033 Liu, 2018, Luteolin promotes the sensitivity of cisplatin in ovarian cancer by decreasing PRPA1-medicated autophagy, Cell. Mol. Biol. (Noisy-le-grand), 10.14715/cmb/2018.64.6.4 Long, 2018, HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells, Pharmazie. Luvero, 2014, Treatment options in recurrent ovarian cancer: Latest evidence and clinical potential, Ther. Adv. Med. Oncol., 10.1177/1758834014544121 Ma, 2019, PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma, Cell Death Dis., 10.1038/s41419-019-1415-6 Mantia-Smaldone, 2011, Targeted treatment of recurrent platinum-resistant ovarian cancer: Current and emerging therapies, Cancer Manag. Res. Meng, 2006, Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway, Cell. Signal, 10.1016/j.cellsig.2006.05.019 Noske, 2007, Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: Increased expression of AKT in advanced ovarian cancer, Cancer Lett., 10.1016/j.canlet.2006.02.018 Park, 2011, IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway, Mol. Immunol., 10.1016/j.molimm.2010.10.020 Peng, 2016, Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells, Exp. Cell Res., 10.1016/j.yexcr.2015.12.006 Piccart, 2003, Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer, Int. J. Gynecological Cancer Qiu, 2017, Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy, Oncol. Rep., 10.3892/or.2017.5706 Razi, 2016, The incidence and mortality of ovarian cancer and their relationship with the human development index in Asia, Ecancermedicalscience, 10.3332/ecancer.2016.628 Sankaranarayanan, 2006, Worldwide burden of gynaecological cancer: The size of the problem, Best Pract. Res. Clin. Obstet. Gynaecol., 10.1016/j.bpobgyn.2005.10.007 Santarelli, 2014, STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells, Sci. Rep., 10.1038/srep04241 Scherz-Shouval, 2007, Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4, EMBO J., 10.1038/sj.emboj.7601623 Sharma, 2014, Cytotoxic autophagy in cancer therapy, Int. J. Mol. Sci., 10.3390/ijms150610034 Shimizu, 2014, Autophagic cell death and cancer, Int. J. Mol. Sci., 10.3390/ijms15023145 Srivastava, 2017, Racial health disparities in ovarian cancer: Not just black and white, J. Ovarian Res., 10.1186/s13048-017-0355-y Tomao, 2017, Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?, Cancer, 10.1002/cncr.30830 Wang, 2004, Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review), Oncol. Rep., 10.3892/or.12.5.955 Wang, 2014, Role of autophagy in cisplatin resistance in ovarian cancer cells, J. Biol. Chem. Wang, 2014, Interleukin-10 blocks in vitro replication of human cytomegalovirus by inhibiting the virus-induced autophagy in MRC5 cells, Biochem. Biophys. Res. Commun. Wu, 2016, Interactions between autophagy and inhibitory cytokines, Int. J. Biol. Sci., 10.7150/ijbs.15194 Xiao, 2016, YAP induces cisplatin resistance through activation of autophagy in human ovarian carcinoma cells, Onco. Targets. Ther. Zhang, 2015, TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer, Autophagy, 10.1080/15548627.2014.998931